Recent News Featured June 12, 2026 Epion Therapeutics Completes Phase 3 Clinical Program for EpiSmart® Epithelium-On Corneal Cross-Linking June 12, 2026 June 12, 2026 October 13, 2025 FDA Awards Fast Track Designation to Epion Therapeutics for its EpiSmart Epithelium-On Cross-Linking System October 13, 2025 October 13, 2025
